AlphaYou
Overview
Smart money at a glance
Filings to Oct 5, 2026Net selling: insiders sold $3.3M and bought $0 on the open market in 90 days (SEC Form 4). Congress: net buying of $1K to $15K in 180 days.
- Company insidersSEC Form 4, last 90 days
- -$3.3M netNet selling
- CongressSTOCK Act, last 180 days
- +$1K to +$15K netNet buying
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 2 added, 0 cutMore adding
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Market overview
Fundamentals Oct 5- Open
- $52.51
- 52-wk high
- $61.70
- High
- $55.25
- 52-wk low
- $25.36
- Low
- $52.00
- Prev close
- $53.59
- Mkt cap
- $2.80B
- P/E
- 262.6x
- Volume
- 1.62M
- Fwd P/E
- 232.6x
- Beta
- 1.26
- P/S
- 4.9x
- P/B
- 5.8x
- Profit margin
- +1.8%
- Op margin
- +6.3%
- ROE
- +2.1%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about ATRC filings
Are insiders buying or selling AtriCure Inc (ATRC) stock?
Net selling: insiders sold $3.3M and bought $0 of ATRC stock on the open market in the 90 days to Oct 5, 2026, according to SEC Form 4 filings. $880K of the sales were made under pre-set Rule 10b5-1 trading plans. The largest was Wehrwein, Sven (Director), who sold $946K. The latest filing was on Sep 24, 2026.
Which members of Congress have traded ATRC recently?
Rep. Gilbert Cisneros (D) bought $1K to $15K on Aug 20, 2026, disclosed 21 days later. In total, 1 member disclosed 1 ATRC trade with trade dates in the last 180 days, filed a median 21 days after trading.
How current is this ATRC smart-money data?
This summary uses filings available on Oct 5, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Buys/Adds (3)
- AQ
AQR
$9.9M
added
- MW
Marshall Wace
$5.7M
added
- FM
FMR LLC
$4.6M
added
What insiders are doing
What Congress is doing
Buys (1)
How top traders are positioned
No tracked top-trader positions in ATRC right now.
Live Hyperliquid positioning - not every stock is covered
Activist stakes, short interest & more
Earnings
Earnings came in $0.16 a share above what analysts expected.
Last report
Jul 23, 2026
Period ending
Jun 30, 2026
Adjusted EPS
$0.02 expected
Revenue
No reported revenue on record
Previous reports
All values in USD| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 23, 2026 | $0.18 / $0.02Yahoo Finance | +$0.16 beat | Unavailable | Unavailable |
| Mar 31, 2026 | May 5, 2026 | $0.00 / -$0.06Yahoo Finance | +$0.06 beat | Unavailable | Unavailable |
| Dec 31, 2025 | Feb 17, 2026 | $0.06 / -$0.04Yahoo Finance | +$0.10 beat | Unavailable | Unavailable |
| Sep 30, 2025 | Oct 29, 2025 | -$0.01 / -$0.12Yahoo Finance | +91.49% beat | Unavailable | Unavailable |
| Jun 30, 2025 | Jul 29, 2025 | -$0.02 / -$0.16Alpha Vantage | +87.50% beat | Unavailable | Unavailable |
| Mar 31, 2025 | Apr 29, 2025 | -$0.14 / -$0.22Alpha Vantage | +36.36% beat | Unavailable | Unavailable |
| Dec 31, 2024 | Feb 12, 2025 | -$0.08 / -$0.15Alpha Vantage | +46.24% beat | Unavailable | Unavailable |
| Sep 30, 2024 | Oct 29, 2024 | -$0.17 / -$0.20Alpha Vantage | +15.00% beat | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
Reports Oct 27, 2026, in 22 days
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $134.3M | $140.5M | $141.2M | $153.6M |
| Cost of what it sold | $32.9M | $35.9M | $31.9M | $35.0M |
| Gross profit | $101.3M | $104.6M | $109.3M | $118.6M |
| What it spent | ||||
| Research and development | $22.9M | $22.7M | $24.2M | $26.4M |
| Sales and admin | $78.2M | $78.3M | $84.5M | $82.6M |
| Total operating expenses | $101.1M | $101.1M | $108.8M | $109.0M |
| What was left | ||||
| Operating profit | $208.0K | $3.5M | $526.0K | $9.7M |
| Interest on debt | $2.9M | $1.5M | $1.3M | $1.3M |
| Profit before tax | -$86.0K | $2.4M | $394.0K | $9.4M |
| Tax | $181.0K | $604.0K | $286.0K | $471.0K |
| Net profit | -$267.0K | $1.8M | $108.0K | $9.0M |
| EBITDA | $8.0M | $9.0M | $7.0M | $3.2M |
Technicals
Price structure
This stock is in a strong uptrend.
Trend
Strong uptrend
80 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage leans bearish
Freedom Capital downgrades AtriCure stock rating to hold, raises price target to $57
NeutralOct 2Price to cash flow ratio of AtriCure, Inc. – HAN:A5I
NeutralOct 1Debt to assets ratio of AtriCure, Inc. – HAN:A5I
NeutralSep 30How Device Adoption Growth Will Impact AtriCure (ATRC) Stock
Leans bullishSep 26AtriCure (ATRC) Stock Looks Rich Against Its Sales Base
Leans bearishSep 25Atricure Insider Sold Shares Worth $271,140, According to a Recent SEC Filing
Leans bearishSep 25AtriCure CTO Salvatore Privitera sells $271,140 in stock
NeutralSep 25AtriCure CTO Salvatore Privitera sells $271,140 in stock By Investing.com
NeutralSep 25
Macro
21 macro signals shaping ATRC right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results